{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:24Z","timestamp":1753891524816,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease, and the potential risk of cancer in patients with CIDP remains an important concern during treatment. However, a comprehensive epidemiological study examining this association is yet to be conducted. This study aimed to investigate the incidence of cancer in patients with CIDP in South Korea using data from the Korean Health Insurance Review and Assessment Service (HIRA) database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from the HIRA database between January 2016 and June 2021 were analyzed. The actual incidence of cancer in patients with CIDP was compared with the expected incidence based on the general population statistics in South Korea, with adjustments for age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 888 patients with CIDP were included in the analysis, of whom 50 (5.63% of malignancy incidence) were newly diagnosed with cancer during the study period. Among the patients with CIDP diagnosed with cancer, 32 (64.00%) were aged 60\u2009years or older, and 36 (72.00%) were male. The observed number of cancer diagnoses corresponded to an incidence rate of 5.63%, with a standardized incidence ratio (SIR) of 2.83 (95% confidence interval [CI]: 1.89\u20134.39) compared to the expected cancer incidence rate of 2.00%. Notably, the SIR for malignancies of lymphoid, hematopoietic, and related tissues, excluding malignant immunoproliferative diseases, multiple myeloma, and plasma cell neoplasms (C81-96, except C88 and C90), was the highest at 8.51 (95% CI: 4.18\u201319.83).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study shows a potential association between CIDP and an increased risk of hematological malignancies, which is consistent with previous investigations. Further studies are required to better understand the relationship between CIDP and cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1456835","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:28:24Z","timestamp":1724905704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of cancer in chronic inflammatory demyelinating polyneuropathy: a nationwide cohort study in South Korea"],"prefix":"10.3389","volume":"15","author":[{"given":"Kyomin","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gucheol","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","article-title":"Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment","volume":"90","author":"Lehmann","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11940-009-0026-4","article-title":"Inflammatory demyelinating neuropathies","volume":"11","author":"Muley","year":"2009","journal-title":"Curr Treat Options Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1007\/s00415-020-09998-8","article-title":"Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"268","author":"Querol","year":"2021","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/jamainternmed.2016.1548","article-title":"Association of Leisure-Time Physical Activity with Risk of 26 types of Cancer in 1.44 million adults. JAMA","volume":"176","author":"Moore","year":"2016","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/mus.26028","article-title":"Chronic inflammatory demyelinating polyneuropathy and malignancy: a systematic review","volume":"57","author":"Rajabally","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e2014008","DOI":"10.4178\/epih\/e2014008","article-title":"A guide for the utilization of Health Insurance Review and Assessment Service national patient samples","volume":"36","author":"Kim","year":"2014","journal-title":"Epidemiol Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"dyw253","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Seong","year":"2016","journal-title":"Int J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0190182","DOI":"10.1371\/JOURNAL.PONE.0190182","article-title":"Cancer risk in Korean patients with Beh\u00e7et\u2019s disease: a nationwide population-based study","volume":"12","author":"Jung","year":"2017","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00296-019-04408-3","article-title":"Malignancy risk in Korean male patients with ankylosing spondylitis","volume":"39","author":"Nam","year":"2019","journal-title":"Rheumatol Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12882-018-1110-3","article-title":"Cancer risk after renal transplantation in South Korea: a nationwide population-based study","volume":"19","author":"Heo","year":"2018","journal-title":"BMC Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for Health Research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"year":"2022","key":"ref15"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/J.AMEPRE.2013.10.029","article-title":"Age and Cancer risk: a potentially modifiable relationship","volume":"46","author":"White","year":"2014","journal-title":"Am J Prev Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/mus.21206","article-title":"Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e000037","DOI":"10.1136\/bmjonc-2023-000037","article-title":"Use of immunosuppression and subsequent cancer incidence: cohort study","volume":"2","author":"Buchanich","year":"2023","journal-title":"BMJ Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin Cancer in organ transplant recipients: systematic review and Meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am J Transplant"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of Cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of Cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case\u2013control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"101907","DOI":"10.1016\/j.msard.2019.101907","article-title":"Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody","volume":"39","author":"Kojima","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"102712","DOI":"10.1016\/j.autrev.2020.102712","article-title":"Update in immunosuppressive therapy of myasthenia gravis","volume":"20","author":"Lascano","year":"2021","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/ajt.17021","article-title":"Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation","volume":"22","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2022","journal-title":"Am J Transplant"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2015.06.003","article-title":"Lymphoma-associated dysimmune polyneuropathies","volume":"355","author":"St\u00fcbgen","year":"2015","journal-title":"J Neurol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/nop\/npv025","article-title":"Neuropathies associated with lymphoma\u2020","volume":"2","author":"Grisold","year":"2015","journal-title":"Neurooncol Pract"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/mus.20163","article-title":"Lymphoma and peripheral neuropathy: a clinical review","volume":"31","author":"Kelly","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/0284186X.2021.1917776","article-title":"Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin\u2019s lymphoma; symptom burden and quality of life","volume":"60","author":"Eikeland","year":"2021","journal-title":"Acta Oncol (Madr)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-009-9848-x","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin","volume":"94","author":"Palma","year":"2009","journal-title":"J Neuro-Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1212\/WNL.44.12.2404","article-title":"Demyelinating neuropathies triggered by melanoma immunotherapy","volume":"44","author":"Fuller","year":"1994","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4143\/crt.2017.166","article-title":"Nationwide trends in the incidence of melanoma and non-melanoma skin cancers from 1999 to 2014 in South Korea","volume":"50","author":"Oh","year":"2018","journal-title":"Cancer Res Treat"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<850::AID-MUS2>3.0.CO;2-5","article-title":"Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-hu antibodies: Clinicopathological study of an autopsy case","volume":"21","author":"Antoine","year":"1998","journal-title":"Muscle Nerve"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1456835\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:28:26Z","timestamp":1724905706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1456835\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":34,"alternative-id":["10.3389\/fneur.2024.1456835"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1456835","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"article-number":"1456835"}}